- •Uveitis
- •Foreword
- •Preface
- •Dedication
- •Acknowledgments
- •Elements of the Immune System and Concepts of Intraocular Inflammatory Disease Pathogenesis
- •Elements of the immune system
- •Macrophages/monocytes
- •Dendritic cells
- •T cells
- •Major subsets of T cells
- •Cytokines
- •T-cell subsets
- •T-regulatory cells
- •T-cell receptor
- •Chemokines
- •Thymic expression and central immune tolerance
- •B cells
- •Classes of Immunoglobulin
- •Other cells
- •Mast Cells
- •Eosinophils
- •Neutrophils
- •Resident Ocular Cells
- •Complement system
- •Cellular interactions: hypersensitivity reactions
- •Classic immune hypersensitivity reactions
- •Type I
- •Type II
- •Type III
- •Type IV
- •Type V
- •Concepts of disease pathogenesis
- •Immune characteristics of the eye
- •Absence of lymphatic drainage
- •Intraocular microenvironment
- •Anterior Chamber-Associated Immune Deviation (ACAID)
- •Fas-Fas Ligand Interactions and Programmed Cell Death (Apoptosis)
- •Resident Ocular Cells and Immune System
- •Cytokines and Chemokines and the Eye
- •Oral Tolerance
- •Choroidal circulation and anatomy
- •Retina
- •Immunogenetics
- •Class I antigens
- •Class II and class III antigens
- •Histocompatibility lymphocyte antigens
- •Single-nucleotide polymorphisms (SNPs)
- •Epigenetics
- •Immune complex-mediated disease
- •Gene expression profiling
- •Tissue damage in the eye
- •T-cell responses and autoimmunity
- •T-cell receptor and the expression of disease
- •Ocular autoimmunity
- •Uveitogenic antigens
- •Retinal S-Antigen (Arrestin)
- •Interphotoreceptor Retinoid-Binding Protein
- •Recoverin
- •Bovine Melanin Protein
- •Rhodopsin
- •Phosducin
- •Tyrosinase
- •Other Antigens
- •Endotoxin and Other Bacterial Antigens
- •Importance of Antigen Studies
- •Cell adhesion molecules and their role in lymphocyte homing and in disease
- •Immune responses to invading viruses and parasites
- •Suggested Readings
- •References
- •Medical History in the Patient with Uveitis
- •References
- •Sample Uveitis Questionnaire
- •FAMILY HISTORY
- •SOCIAL HISTORY
- •PERSONAL MEDICAL HISTORY
- •MEDICAL HISTORY
- •Examination of the Patient with Uveitis
- •Visual acuity
- •External examination
- •Pupils and extraocular muscles
- •Intraocular pressure measurement
- •Slit-lamp biomicroscopy
- •Conjunctiva
- •Cornea
- •Keratic Precipitates
- •Other Corneal Findings
- •Anterior chamber
- •Iris
- •Anterior chamber angle
- •Lens
- •Vitreous
- •Retina and choroid
- •Optic nerve
- •References
- •Development of a Differential Diagnosis
- •Forming a differential diagnosis
- •Classifying uveitis
- •Is the disease acute or chronic?
- •Is the inflammation granulomatous or nongranulomatous?
- •Is the disease unilateral or bilateral?
- •Where is the inflammation located in the eye?
- •What are the demographics of the patient?
- •What associated symptoms does the patient have?
- •What associated signs are present on physical examination?
- •What is the time course of the disease and response to previous therapy?
- •Case 4-1
- •Case 4-2
- •References
- •Diagnostic Testing
- •Pretest likelihood of disease
- •Receiver operating characteristic (ROC) curve
- •Diagnostic tests for uveitis
- •Laboratory tests
- •Image analysis
- •Skin testing
- •Tissue samples
- •Ancillary ophthalmic tests
- •Electrophysiology
- •Laser interferometry
- •Fluorescein angiography
- •Indocyanine green
- •Laser flare photometry
- •Optical coherence tomography
- •High-frequency ultrasound biomicroscopy and multifrequency ultrasound
- •Fundus autofluorescence
- •Other diagnostic tests
- •Polymerase chain reaction (PCR)
- •Rapid tests for herpes simplex and herpes zoster
- •Bone mineral density studies
- •Genetic testing for steroid-induced glaucoma
- •Neurologic tests
- •References
- •Evidence-Based Medicine in Uveitis
- •Study design
- •Clinical trials in uveitis
- •References
- •Philosophy, Goals, and Approaches to Medical Therapy
- •Goals and philosophy
- •Pain, photophobia, and discomfort
- •Degree and location of inflammatory disease
- •Evaluation of visual acuity and prospect of reversibility
- •Follow-up procedures and standardization of observations
- •General health and age of patient
- •Patient reliability, preferences, and understanding
- •Nonsurgical therapeutic options
- •Corticosteroids
- •Mode of Action
- •Preparations, Dosage Schedules, and Complications
- •Ozurdex.
- •Secondary Effects
- •Cytotoxic agents
- •Alkylating agents
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Antimetabolites
- •Azathioprine
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Mycophenolate mofetil
- •Methotrexate
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Ciclosporin
- •Mode of Action
- •Dosages and Indications
- •Secondary Effects
- •Tacrolimus
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Lx 211 (Voclosporin)
- •Rapamycin
- •Mode of Action
- •Indications and Dosages
- •Toxicity
- •Antibodies and monoclonal antibodies
- •Daclizumab
- •Etanercept
- •Infliximab (Remicade)
- •Adalimumab (Humira)
- •Efalizumab (Raptiva)
- •Rituximab (Rituxan)
- •Anakinra (Kineret)
- •Alemtuzumab (Campath-1H)
- •Abatacept (Orencia)
- •Intravenous immunoglobulin therapy
- •Oral tolerance
- •Interferon-α
- •Antiviral therapy
- •Aciclovir
- •Ganciclovir
- •Valaciclovir
- •Famciclovir
- •Foscarnet
- •Combined ganciclovir and foscarnet
- •Cidofovir
- •Fomivirsen
- •Colchicine
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Mydriatic and cycloplegic agents
- •Antitoxoplasmosis therapy
- •Other therapeutic approaches
- •Immunostimulators
- •Plasmapheresis
- •Nonsteroidal antiinflammatory agents
- •References
- •Role of Surgery in the Patient with Uveitis
- •Considerations
- •Removal of band keratopathy
- •Corneal transplantation
- •Cataract surgery
- •Glaucoma surgery
- •Treatment of vitreoretinal disease
- •Laser treatment
- •Photodynamic therapy
- •Diagnostic surgery
- •Anterior chamber paracentesis
- •Chorioretinal biopsy
- •Subretinal surgery
- •Case 8-1
- •References
- •Bacterial and Fungal Diseases
- •Introduction
- •Leprosy
- •Clinical findings
- •Immunology and pathology
- •Therapy
- •Tuberculosis
- •Systemic disease
- •Ocular disease
- •Diagnosis
- •Therapy
- •Other bacterial infections
- •Brucellosis
- •Whipple’s disease
- •Treatment and prognosis
- •Chronic granulomatous disease
- •Fungal disease
- •Neuroretinitis
- •References
- •Spirochetal Diseases
- •Spirochetal infections and the eye
- •Spirochetes
- •Definition
- •Venereal treponemal diseases
- •Syphilis
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Primary syphilis.
- •Secondary syphilis.
- •Latent syphilis.
- •Tertiary syphilis.
- •Benign tertiary syphilis.
- •Cardiovascular syphilis.
- •Neurosyphilis.
- •Congenital syphilis.
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •General recommendations.
- •Approach to Syphilis in Patients with AIDS
- •Nonvenereal treponematoses
- •Endemic syphilis
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •Yaws and pinta
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •Borrelia infection
- •Lyme disease
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •Relapsing fever
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •Leptospirosis
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Ocular Manifestations
- •Weil’s disease
- •Diagnosis
- •Prognosis
- •Treatment
- •Case 10-1
- •References
- •Acquired Immunodeficiency Syndrome
- •Human immunodeficiency virus
- •Epidemiology
- •Diagnosis
- •HIV disease
- •HIV therapy
- •Ocular manifestations of HIV infection
- •Ocular infection
- •Cytomegalovirus retinitis
- •Progression
- •CMV retinitis in the era of highly active antiretroviral therapy
- •Treatment
- •Intravitreal ganciclovir implant
- •Current therapeutic approach to CMV retinitis in the era of HAART
- •Retinal detachment
- •Prognosis
- •Immune recovery uveitis
- •Herpes zoster
- •Pneumocystis jirovecii choroiditis
- •Mycobacterium avium-intracellulare choroiditis
- •Other diseases
- •Drug-related ocular inflammation
- •Case 11-1
- •Case 11-2
- •References
- •Acute retinal necrosis
- •Epidemiology
- •Clinical features
- •Etiology
- •Differential diagnosis
- •Therapy
- •Progressive outer retinal necrosis
- •Diagnosis
- •Differential diagnosis
- •Etiology
- •Therapy
- •Case 12-1
- •Case 12-2
- •References
- •Other Viral Diseases
- •Herpes simplex virus kerititis and keratouveitis
- •Pathogenesis
- •Diagnosis
- •Treatment
- •Herpes zoster ophthalmicus
- •Treatment
- •West Nile virus
- •Epidemiology
- •Diagnosis
- •Clinical description
- •Ophthalmic manifestations
- •Treatment
- •Prognosis
- •Other viral infections
- •Human T-lymphotropic virus type I
- •Case 13-1
- •References
- •Ocular Toxoplasmosis
- •Organism
- •Clinical manifestations
- •Systemic
- •Ocular
- •Decreased Vision
- •Loss of Vision
- •Effects in immunocompromised host
- •Histopathology and immune factors
- •Immune response
- •Inflammatory response
- •Methods of diagnosis
- •Pregnancy
- •Other methods
- •Congenital versus acquired disease
- •Therapy
- •Additional therapeutic approaches
- •Case 14-1
- •Case 14-2
- •Case 14-3
- •Case 14-4
- •References
- •Ocular Histoplasmosis
- •Systemic findings
- •Ocular appearance
- •‘Histo’ spots
- •Maculopathy
- •Peripapillary pigment changes
- •Clear vitreous
- •Etiology and immunology
- •Nonsurgical therapies
- •Laser therapy
- •Subretinal surgery
- •References
- •Toxocara canis
- •Ocular manifestations
- •Histopathology and immune factors
- •Enzyme-linked immunoabsorbent assay
- •Treatment
- •Case 16-1
- •References
- •Onchocerciasis and Other Parasitic Diseases
- •Onchocerciasis
- •Clinical appearance
- •Immune characteristics
- •Therapy
- •Giardiasis
- •Ophthalmomyiasis
- •Cysticercosis
- •Caterpillar hairs
- •Amebiasis
- •Diffuse unilateral subacute neuroretinitis (DUSN)
- •Malaria
- •Seasonal hyperacute panuveitis (SHAPU)
- •References
- •Postsurgical Uveitis
- •Acute bacterial endophthalmitis
- •Chronic bacterial endophthalmitis
- •Fungal endophthalmitis
- •Endogenous endophthalmitis
- •Lens-induced uveitis
- •Toxic anterior segment syndrome (TASS)
- •Laser-induced uveitis
- •Case 18-1
- •References
- •Anterior Uveitis
- •Epidemiology
- •Clinical description
- •Idiopathic anterior uveitis
- •Diagnostic workup
- •Treatment
- •HLA-B27–associated anterior uveitis
- •Epidemiology
- •Demographics and clinical findings
- •Etiology
- •HLA-B27–associated anterior uveitis with systemic disease
- •Ankylosing spondylitis
- •Etiology
- •Treatment
- •Reactive arthritis (Reiter’s syndrome)
- •Juvenile idiopathic arthritis
- •Diagnosis
- •Pathology
- •Differential diagnosis
- •Treatment and prognosis
- •Psoriatic arthropathy
- •Inflammatory bowel disease
- •Whipple’s disease
- •Disease associations
- •Fuchs’ heterochromic iridocyclitis
- •Etiology
- •Treatment and prognosis
- •Kawasaki disease
- •Tubulointerstitial nephritis and uveitis syndrome (TINU)
- •Pathogenesis
- •Glaucomatous cyclitic crisis
- •Schwartz syndrome
- •Anterior segment ischemia
- •Lens-induced uveitis
- •Anterior uveitis associated with AIDS
- •Other disease associations
- •References
- •Scleritis
- •Episcleritis
- •Scleritis
- •Disease associations
- •Other causes of scleritis
- •Diagnostic testing
- •Pathogenesis
- •Differential diagnosis
- •Treatment
- •References
- •Intermediate Uveitis
- •Epidemiology
- •Clinical manifestations
- •Prognosis
- •Differential diagnosis
- •Multiple sclerosis
- •Etiology
- •Treatment
- •Corticosteroids
- •Immunosuppressive agents
- •Surgery
- •Case 21-1
- •Case 21-2
- •References
- •Sarcoidosis
- •Epidemiology
- •Etiology
- •Clinical manifestations
- •Anterior uveitis
- •Posterior segment findings
- •Systemic involvement
- •Pathology
- •Diagnosis
- •Treatment
- •Case 22-1
- •References
- •Sympathetic Ophthalmia
- •Clinical appearance and prevalence
- •Classic presentation
- •Sequelae
- •Tests and immunologic characteristics
- •Dalen–fuchs nodules
- •Preservation of the choriocapillaris
- •Therapy
- •Corticosteroids
- •Immunosuppressive agents
- •Case 23-1
- •Case 23-2
- •References
- •Vogt–Koyanagi–Harada Syndrome
- •Clinical aspects
- •Systemic findings
- •Ocular findings
- •Course of disease
- •Laboratory tests, etiology, and histopathology
- •Antigen-specific and immune responses
- •Vogt–Koyanagi–Harada syndrome versus sympathetic ophthalmia
- •Therapy
- •Cataract extraction
- •Case 24-1
- •Case 24-2
- •References
- •Birdshot Retinochoroidopathy
- •Clinical manifestations
- •Ocular examination and ancillary clinical tests
- •Tests, histology and etiology
- •Therapy
- •Case 25-1
- •Case 25-2
- •References
- •Behçet’s Disease
- •Clinical manifestations
- •Oral aphthous ulcers
- •Skin lesions
- •Genital ulcers
- •Ocular disease
- •Retinal disease
- •Complications
- •Minor criteria
- •Arthritis
- •Vascular alterations
- •Neurologic involvement (neuro-Behçet’s disease)
- •Immunologic and histologic considerations
- •Role of T cells (but other cells count too!)
- •HLA typing and single nucleotide polymorphisms (SNPs)
- •Therapy
- •Systemic corticosteroids
- •Cytotoxic and antimetabolic agents
- •Colchicine
- •Interferon-α
- •Ciclosporin and tacrolimus (FK506)
- •Anti-TNF therapy (infliximab)
- •Other approaches
- •Case 26-1
- •Case 26-2
- •Case 26-3
- •References
- •Retinal Vasculitis
- •Clinical characteristics
- •Ocular vasculitic disorders without systemic disease
- •Eales’ disease
- •Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN syndrome)
- •Frosted branch angiitis
- •Scleritis
- •Ocular vasculitic disorders with systemic disease
- •Systemic lupus erythematosus
- •Polyarteritis nodosa
- •Wegener’s granulomatosis
- •Whipple’s disease
- •Inflammatory bowel disease
- •Autoantibodies to Sjögren’s syndrome A antigen
- •Retinal vein occlusion
- •Relapsing polychondritis
- •Viral diseases
- •Multiple sclerosis
- •Tuberculosis
- •Rheumatoid arthritis
- •Kikuchi–Fujimoto disease
- •Susac syndrome
- •Sweet syndrome
- •References
- •Serpiginous Choroidopathy
- •Clinical features
- •Pathology
- •Etiology
- •Differential diagnosis
- •Therapy
- •Case 28-1
- •Case 28-2
- •Case 28-3
- •References
- •White-Dot Syndromes
- •Multiple evanescent white-dot syndrome
- •Clinical findings
- •Laboratory findings
- •Therapy
- •Multifocal choroiditis and panuveitis
- •Clinical findings
- •Punctate inner choroidopathy
- •Laboratory findings
- •Therapy
- •Acute retinal pigment epitheliitis
- •Clinical findings
- •Laboratory findings
- •Therapy
- •Acute posterior multifocal placoid pigment epitheliopathy
- •Clinical findings
- •Etiology
- •Therapy
- •Subretinal fibrosis and uveitis syndrome
- •Clinical findings
- •Laboratory findings
- •Therapy
- •Acute zonal occult outer retinopathy (AZOOR) and the azoor complex diseases
- •Case 29-1
- •Case 29-2
- •Case 29-3
- •References
- •Masquerade Syndromes
- •Intraocular lymphoma
- •Non-Hodgkin’s lymphoma of central nervous system
- •Diagnosis
- •Treatment
- •Systemic Non-Hodgkin’s lymphoma metastatic to eye
- •Lymphoid hyperplasia of uvea
- •Other malignant processes manifesting as uveitis
- •Paraneoplastic syndromes
- •Multiple sclerosis
- •Other nonmalignant conditions
- •References
- •Introduction
- •Age-related macular degeneration
- •Animal work
- •Animal laser model
- •Ccl2 and Ccr2 knockout model
- •Ccl2 and Cx3cr1 double knockout model
- •CEP induced AMD-like disease
- •Human data
- •Autoimmunity
- •Gene associations
- •Macrophages and other cells
- •Histopathology
- •The downregulatory immune environment
- •Should we consider immunotherapy?
- •Diabetic retinopathy
- •Diabetes and the immune process
- •Animal work
- •Human observations
- •Can we begin to think about immune therapy for diabetes and diabetic retinopathy?
- •Glaucoma
- •Autoantibodies and glaucoma
- •Cellular immunity and glaucoma
- •Can immune intervention help alter the course of glaucoma?
- •References
- •Index
Part 4 • Infectious Uveitic Conditions
Chapter 10 Spirochetal Diseases
diagnosis of yaws and pinta is based on clinical findings in the setting of positive syphilis serologic findings.
Prognosis
Yaws may undergo spontaneous clinical and serologic resolution at any stage of the disease without therapy; however, antibiotic treatment improves the cure rate. Untreated patients may experience periarticular ulcers causing crippling contractures and osteomyelitis. Patients with untreated pinta experience depigmented patches of the skin, which may lead to social ostracization, the major consequence of pinta.
Treatment
Penicillin is the preferred drug to treat yaws and pinta. The treatment recommendations are outlined in the section on endemic syphilis.
Borrelia infection
Lyme disease
Etiology and Epidemiology
In the spring and summer of 1975, a group of children living in Lyme, Connecticut, presented with an inflammatory arthropathy similar to that in juvenile rheumatoid arthritis.43 A characteristic rash was associated with the illness, as were neurologic and cardiac abnormalities. In 1977 Steere and others43 labeled this illness Lyme disease. Epidemiologic studies implicated ticks as the vector for the disease, but the etiologic agent remained elusive.
Similar rashes called erythema migrans or erythema chronicum migrans had been associated with tick bites and systemic disease in Europe, and spirochete-like structures had been found in skin specimens from several patients.44 In the United States, evidence was accumulating that patients with Lyme disease who were treated with penicillin fared better than untreated patients. A tick-borne organism was suspected as the causative agent, and in 1982, Burgdorfer and coworkers45 found spirochetes in Ixodes dammini ticks while looking for the cause of Rocky Mountain Spotted Fever in their Montana laboratory. Spirochetes were later isolated from patients with Lyme disease in the United States, as well as from patients in Europe with erythema migrans and Bannwarth’s syndrome (a chronic lymphocytic meningitis associated with erythema chronicum migrans).46 The previously unrecognized spirochete was isolated by Burgdorfer and Barbour47 and was named Borrelia burgdorferi.
Along with Leptospira and Treponema, Borrelia belongs to the eubacterial phylum of spirochetes.48 These organisms are usually more loosely coiled than other spirochetes, but if coiled, they have a corkscrew appearance and look exactly like T. pallidum. Borrelia species are easy to isolate from infected ticks but difficult to isolate from infected patients. B. burgdorferi is transmitted by certain Ixodes ticks. In the United States, the preferred host for the larval and nymphal forms of the tick is the white-footed mouse,49 whereas the preferred host for the adult form of the tick is the whitetailed deer.50 The ticks have now been found on at least 30 species of animal and 49 species of bird.51 Lyme disease also occurs in domestic animals, including cats, dogs, and horses. Ixodes ticks are ‘multitalented’ and transmit babesiosis and tularemia in addition to Lyme disease.
From 1980 to 1988, 13 795 cases of Lyme disease were reported in the United States.52 During 1992–2006 a total of 248 074 cases of Lyme disease were reported in the 50 states, the District of Columbia, and US territories.53 The annual count increased 101% from 9908 cases in 1992 to 19 931 cases in 2006. Most of the cases were reported from 10 states (Connecticut, Delaware, Massachusetts, Maryland, Minnesota, New Jersey, New York, Pennsylvania, Rhode Island, and Wisconsin).53 Lyme disease is thought to be the most common vector-borne infection in the US, and it has been reported throughout the world, especially North America, Europe, and Asia. The rapid spread of the disease has been attributed to an increase in forested areas that house the tick-infested deer and to the migration of susceptible residents into these areas. For example, during a 7-year period 35% of 190 residents living adjacent to a nature preserve in Ipswich, Massachusetts, acquired Lyme disease.54 The number of cases continues to grow as awareness of the disease by both physicians and patients increases.
Clinical Manifestations
Lyme disease is usually described as occurring in stages (Box 10-3). Early infection is divided into stage 1 (local) and stage 2 (disseminated). Late infection is categorized as stage 3 (persistent). After infection, the spirochete spreads locally in the skin in 60–80% of patients and causes the characteristic rash, erythema migrans,51,55 which is an oval or anular erythematous lesion with expanding borders that usually fades within 3–4 weeks in untreated patients but may recur later in the disease (Fig. 10-5). Patients recall being bitten by a tick about half of the time. Specific antibody to B. burgdorferi is often lacking at this stage of the disease, during which patients may have minor flu-like constitutional symptoms and regional lymphadenopathy. The most common ocular finding in early Lyme disease is conjunctivitis.55
Stage 2 disease occurs within days to weeks after infection, during which time the spirochete can spread to many organs via the blood, causing a multitude of signs and symptoms. These systemic manifestations are mainly characterized by cardiac and neurologic involvement, although patients may experience secondary anular skin lesions. Neurologically, patients have severe headache and mild stiffness of the neck. The CSF is normal early on in the disease but later reveals a lymphocytic pleocytosis with a cell count in the range of 100/mm3, elevated protein concentration, and normal glucose concentration.56 Peripheral neuropathies, intermittent arthralgia, and musculoskeletal pain are common, and unilateral and bilateral Bell’s palsy is the most common cranial neuropathy.57
Box 10-3 Lyme disease – key features
•Caused by the spirochete Borrelia burgdorferi
•Transmitted in the Ixodes dammini tick
•Disease is divided into stages. Early infection is divided into stage 1 (local) and stage 2 (disseminated). Late infection is categorized as stage 3 (persistent)
•After infection the spirochete spreads locally in the skin in 60–80% of patients, causing the characteristic erythema migrans rash
•Conjunctivitis is the most common ocular finding in early Lyme disease
150
Spirochetes
Figure 10-5. Characteristic lesions of erythema migrans associated with Lyme disease.
Figure 10-6. Retinal vasculitis in a patient with ocular Lyme disease. Sheathing of peripheral retinal vessels and mild vitritis are seen in this patient on this fluorescein angiogram. The patient also had a scleritis.
The ocular findings resolved after treatment with intravenous ceftriaxone.
From 4% to 8% of patients have cardiac involvement with fluctuating atrioventricular block.58 Fewer patients have been reported with acute myopericarditis. About 6 months after infection patients can acquire oligoarticular arthritis with a white blood cell count in joint fluid of 500–110 000/mm3. Other manifestations of stage 2 Lyme disease include hepatitis, nonproductive cough, microscopic hematuria or proteinuria, and orchitis.51 The ocular findings most commonly reported in stage 2 disease are conjunctivitis and uveitis.
Stage 3 infection is characterized by prolonged episodes of arthritis. Chronic neurologic manifestations include ataxia, chronic encephalomyelitis, spastic paraparesis, and dementia. Patients often have chronic fatigue, and erythema migrans can occur late in the disease. Bilateral keratitis is described as a characteristic finding in late infection.57–61
Transplacental transmission of B. burgdorferi has been reported in two infants whose mothers had Lyme disease in the first trimester of pregnancy,62–64 although a study of 463 infants from endemic or nonendemic areas showed no association between congenital malformations and the presence of detectable antibody to B. burgdorferi in cord blood.65
Ocular Manifestations
In initial reports, the only consistently reported ocular finding in Lyme disease was transient conjunctivitis, occurring in 11% of persons with stage 1 disease.55 Other ocular findings reported in the early stages of disease include epi scleritis, iridocyclitis with posterior synechiae, and retinal vasculitis (Fig. 10-6).66,67 Steere and associates68 reported on a case of a 45-year-old woman who, 4 weeks after the onset of erythema migrans, experienced unilateral iritis followed by panophthalmitis; spirochetes were found in specimens of vitreous debris obtained at surgery.
In March 1987, Bertuch and associates59 reported on three patients with ocular findings of Lyme disease. The first patient presented with bilateral Bell’s palsy and lateoccurring optic neuritis. The other two patients experienced patchy intrastromal infiltrates of the cornea from Bowman’s layer to Descemet’s membrane. These corneal infiltrates caused reduced vision but no pain, and occurred late in the course of disease. Dramatic resolution of the keratitis occurred after treatment with topical corticosteroids, suggesting an immune mechanism rather than a direct infection
Figure 10-7. Multiple intrastromal lesions of Lyme keratitis. (Courtesy of Ernest Kornmehl, M.D., From Albert & Jacobiec, Principles and Practices of Opthalmology, Copyright Elsevier.)
with the spirochete. Baum and associates60 reported three patients who acquired bilateral keratitis long after Lyme disease was diagnosed and treated, and also noted the effectiveness of topical corticosteroid therapy. Since then, several other papers have documented keratitis late in the course of Lyme disease (Fig. 10-7).61,66,67,69–72
Less common ocular findings associated with Lyme disease have also been reported in single case reports. Bialasiewicz and associates73 described a patient with meningeal symptoms and diffuse choroiditis, cystoid macular edema, and exudative retinal detachments initially misdiagnosed as Vogt–Koyanagi–Harada disease. Immunofluorescence results for Lyme disease were positive, and the patient improved markedly after treatment with doxycycline. Koch and associates74 reported retinal pigment epithelial detachments in a man with neuroborreliosis. Scholes and Teske75 tested 19 patients with intermediate uveitis for Lyme disease, and seven of 19 patients had positive antibody titers, suggesting a possible association between Lyme disease and pars planitis. Copeland and associates76 reported on two patients with intermediate uveitis that was only partially responsive to steroids who were later diagnosed with Lyme disease after positive Lyme titers were obtained. The uveitis
151
Part 4 • Infectious Uveitic Conditions
Chapter 10 Spirochetal Diseases
A B
Figure 10-8. A, Right and B, left optic nerve demonstrating pallor after resolution of optic neuritis associated with Lyme disease. (Courtesy of Ernest Kornmehl, M.D., From Albert & Jacobiec, Principles and Practices of Opthalmology, Copyright Elsevier.)
in both patients cleared rapidly with systemic antibiotic treatment. In a report by Winward and colleagues,77 patients with intermediate uveitis associated with Lyme disease demonstrated more significant anterior segment inflammation. Subsequent studies confirmed the presence of significant posterior segment inflammation, especially vitritis and retinal vasculitis, in some cases of Lyme disease.71,72,78,79
Neuro-ophthalmic findings in Lyme disease are common.44,80 Involvement of the CNS by Lyme disease causes cranial nerve palsies. Unilateral and bilateral Bell’s palsies are the most common cranial nerve palsies and often result in exposure keratitis. Diplopia due to sixth, fourth, and third cranial nerve palsies can occur. Wu and associates81 described a 7-year-old child who had bilateral disc edema in association with Lyme disease. A similar patient was described by Jacobson and Frens82 and was diagnosed with a pseudotumor cerebri syndrome associated with Lyme disease. Optic disc edema may be the sole presenting sign of Lyme disease.83 Other reported neuro-ophthalmic manifestations of Lyme disease include optic neuritis (Fig. 10-8), cortical blindness, and orbital myositis.84,85–87 The association of some of these ocular findings with Lyme disease stems from one or two case reports in which the diagnosis of Lyme disease was based predominantly on positive serologic findings. Because serologic results for Lyme disease may be falsely positive, some of the cases may have been wrongly diagnosed.88 A list of the ophthalmic manifestations associated with Lyme disease is presented in Table 10-6.
Diagnosis
Techniques for the diagnosis of Lyme disease are not ideal. A patient with a history of a tick bite who later experiences erythema migrans most surely has Lyme disease; however, a tick bite is recalled in only about 50% of cases, and a pathognomonic rash may be overlooked or may not occur in a significant number of patients. Erythema migrans is the only clinical sign of clear diagnostic value; however, earlobe lymphocytoma, meningoradiculoneuritis (Garin–Bujadoux– Bannwarth syndrome), and acrodermatitis chronica atrophi-
Table 10-6 Ocular manifestations of lyme disease
EARLY INFECTION
Conjunctivitis
Episcleritis
Posterior scleritis
Iridocyclitis
Retinal vasculitis
Optic disc edema
Panophthalmitis
Choroiditis
Pars planitis
Exudative retinal detachment
Retinal pigment epithelial detachment
Exposure keratitis
Diplopia
Cortical blindness
Orbital myositis
LATE INFECTION
Keratitis
Episcleritis
cans may be of some diagnostic value.89 Because of the difficulty of culturing B. burgdorferi from patients, laboratory diagnosis is made by serologic findings. Most patients have elevated antibody titers to B. burgdorferi several weeks after infection. Both immunofluorescent assays and enzymelinked immunosorbent assays (ELISAs) are used in the diagnosis of Lyme disease, although the ELISA is more sensitive in all stages of the disease. Unfortunately, serologic testing has not been standardized, and interlaboratory variability is significant, although improving.90–92 The sensitivity of the ELISA for Lyme disease in several laboratories approaches 90% after the first few weeks of infection. Many laboratories confirm positive ELISA results with Western blot assays. Nevertheless, the clinician must be aware of false-negative and false-positive results. False-negative results occur during the first few weeks of infection, when antibody titers may be low and may be missed by serologic tests of lower sensitivi-
152
- #28.03.202681.2 Mб0Ultrasonography of the Eye and Orbit 2nd edition_Coleman, Silverman, Lizzi_2006.pdb
- #
- #
- #
- #28.03.202621.35 Mб0Uveitis Fundamentals and Clinical Practice 4th edition_Nussenblatt, Whitcup_2010.chm
- #
- #
- #28.03.202627.87 Mб0Vaughan & Asbury's General Ophthalmology 17th edition_Riordan-Eva, Whitcher_2007.chm
- #
- #
- #
